Aquestive Therapeutics, Inc. (AQST)
NASDAQ: AQST · Real-Time Price · USD
3.925
-0.015 (-0.38%)
Feb 10, 2026, 11:46 AM EST - Market open
Aquestive Therapeutics Market Cap
Aquestive Therapeutics has a market cap or net worth of $478.86 million as of February 10, 2026. Its market cap has increased by 69.97% in one year.
Market Cap
478.86M
Enterprise Value
393.01M
1-Year Change
69.97%
Ranking
Category
Stock Price
$3.93
Market Cap Chart
Since July 25, 2018, Aquestive Therapeutics's market cap has increased from $393.23M to $478.86M, an increase of 21.78%. That is a compound annual growth rate of 2.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 9, 2026 | 480.69M | -39.01% |
| Dec 31, 2025 | 788.14M | 142.81% |
| Dec 31, 2024 | 324.59M | 140.67% |
| Dec 29, 2023 | 134.87M | 176.07% |
| Dec 30, 2022 | 48.85M | -68.73% |
| Dec 31, 2021 | 156.24M | -13.14% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jul 25, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ironwood Pharmaceuticals | 787.36M |
| Esperion Therapeutics | 781.63M |
| Emergent BioSolutions | 579.30M |
| Organogenesis Holdings | 486.07M |
| Kamada | 474.56M |
| SIGA Technologies | 468.70M |
| Canopy Growth | 417.56M |
| Akebia Therapeutics | 398.05M |